What question did this study set out to answer?

Summarize the hormonal mechanisms influencing cardiac arrhythmic risk during pregnancy and the postpartum period to provide tailored management strategies for women with congenital long QT syndrome.

March 29, 2021Herzschrittmachertherapie + ElektrophysiologieOpen Access

Arrhythmic risk during pregnancy and postpartum in patients with long QT syndrome

View Full Paper

Ask AI

Bookmark

Why the study?

Adult women with congenital long QT syndrome face sex- and hormone-related differences in arrhythmic risk, requiring comprehensive, gene-specific evaluation and precision management during pregnancy, delivery, and the postpartum period.

Key Points

Summarize the hormonal mechanisms influencing cardiac arrhythmic risk during pregnancy and the postpartum period to provide tailored management strategies for women with congenital long QT syndrome.
Synthesized clinical cohort evidence and translational electrophysiological data on sex hormone fluctuations across gestational and postpartum phases.
Assessed genotype-specific electrophysiological impacts of female sex hormones and postpartum factors on distinct cardiac ion channels.
Arrhythmia risk drops during pregnancy but rises significantly in the postpartum period, driven by opposing actions of estradiol, progesterone, and postpartum hormones on action potential duration.
The pro- or anti-arrhythmic impact of circulating sex hormones differs depending on the patient's underlying genetic mutation and the affected cardiac ion channels.

Structured PICO

Population

Women with congenital long QT syndrome (LQTS) during pregnancy, delivery, and the postpartum period

In women with LQTS, arrhythmic risk decreases during pregnancy but increases significantly postpartum, highlighting the need for uninterrupted beta-blocker therapy and multidisciplinary management.

Discussion

No takes yet. Share an insight, caveat, or question.

Implication

May support sex-specific LQTS risk assessment; leaves open hormonal modulation as therapeutic target.

Cite This Study

Asatryan et al. (2021) studied this question.

synapsesocial.com/papers/6a6fbbd978a11c550e097b5d https://doi.org/10.1007/s00399-021-00757-4

View Full Paper

Ask AI

Bookmark

Arrhythmic risk during pregnancy and postpartum in patients with long QT syndrome

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Arrhythmic risk during pregnancy and postpartum in patients with long QT syndrome

Key Points

Structured PICO

Discussion

Implication

Cite This Study

Also Consider

Also Consider